ELVN

News Enliven Therapeutics' Chief Medical Officer Sold 5,000 Company Shares. Here's What That Means for Investors.

17h ago

Insider trade Sale by Collins Helen Louise (CHIEF MEDICAL OFFICER)

12d ago

News Enliven Posts Loss Beat and Cash Surge

14d ago

News Enliven Therapeutics COO sells over $1.25m in company stock - Investing.com

14d ago

Insider trade Sale by Helen Louise Collins (CHIEF MEDICAL OFFICER)

38d ago

Insider trade Sale by Helen Louise Collins (CHIEF MEDICAL OFFICER)

41d ago

Insider trade Sale by Helen Louise Collins (CHIEF MEDICAL OFFICER)

74d ago

Insider trade Sale by Joseph P Lyssikatos (CHIEF SCIENTIFIC OFFICER)

104d ago

Insider trade Sale by Anish Patel

104d ago

Insider trade Sale by Joseph P Lyssikatos

104d ago

Insider trade Sale by Richard A. Heyman

104d ago

News Ford Q4 earnings on deck: What to expect

112d ago

News Enliven surges after early-stage trial data for leukemia therapy

144d ago